ReviewBreast cancer (Dove Medical Press)2024

Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review.

Meixi Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.